Welcome to our dedicated page for CARECLOUD news (Ticker: CCLDO), a resource for investors and traders seeking the latest updates and insights on CARECLOUD stock.
News for CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (Nasdaq: CCLDO) is closely tied to the operating and capital markets activities of CareCloud, Inc., a healthcare technology and AI-focused company. Investors following CCLDO typically monitor company announcements about preferred stock dividends, redemption terms, financial performance, acquisitions, and AI product launches, since these developments provide context for the preferred security.
CareCloud regularly issues press releases detailing its preferred stock dividend policies and payments. For the Series B Preferred Stock, the company has announced monthly cash dividends, described the cumulative nature of those dividends, and outlined record and payment dates. It has also communicated plans to address accumulated dividend arrears on the Series B Preferred Stock through double monthly dividend payments that combine regular dividends with catch-up payments until past due amounts are fully satisfied.
Beyond dividend-specific updates, the news flow includes information about CareCloud’s broader business performance and strategy. The company has reported quarterly financial results, discussed revenue guidance, and highlighted periods of positive GAAP net income and adjusted EBITDA. It has also described acquisitions such as Medsphere’s hospital IT business and HFMA’s MAP App, which expand its presence in hospital and integrated health system markets and support its AI-driven revenue cycle and benchmarking capabilities.
CareCloud’s news also covers AI product introductions and enhancements, including the launch of stratusAI Desk Agent, an AI phone receptionist for patient access, and the integration of stratusAI Voice Audit for conversational intelligence and call analytics. Additional announcements describe the deployment of the Wellsoft emergency department information system in urgent care settings and the company’s AI Center of Excellence, which supports innovation across inpatient and ambulatory EHR, RCM, analytics, and patient engagement.
Investors and observers who track CCLDO can use this news stream to see how CareCloud’s dividend practices, redemption options, AI initiatives, acquisitions, and financial performance evolve over time. These updates provide insight into both the preferred stock’s income characteristics and the underlying healthcare technology platform that supports the issuer.
CareCloud (Nasdaq: CCLD) announced a new contract with Memorial Hospital in Marysville, Ohio to deploy the HealthLine clinical supply chain platform. HealthLine, acquired via CareCloud's August 2025 purchase of Medsphere, aims to reduce supply waste, improve charge capture, and free clinicians from manual inventory tasks.
The platform delivers point-of-use scanning, automated charge capture, mobility, specialized modules for high-cost areas, and a modern architecture; CareCloud plans to add AI capabilities over coming quarters to boost efficiency and insights.
CareCloud (NASDAQ: CCLD) announced that its Wellsoft Emergency Department Information System was ranked #1 EHR for Emergency Medicine by Black Book 2026. Black Book's ranking is based on independent surveys of 33,178 physician practices and ambulatory facilities collected over nine months and highlights Wellsoft's ED-ready workflow speed, throughput visibility, and operational reliability.
Wellsoft joined CareCloud through the acquisition of Medsphere and has prior recognition from KLAS more than ten times. CareCloud said Affinity Urgent Care selected Wellsoft for its Houston-Galveston clinics, positioning the company to expand emergency-grade EDIS into the ~11,000 urgent care facility U.S. market and to integrate with its revenue cycle, analytics, and AI solutions.
CareCloud (Nasdaq: CCLD, CCLDO) declared monthly cash dividends for its 8.75% Series A and Series B perpetual preferred shares for January, February and March 2026, and an additional Series B dividend to cover an arrearage.
The declared monthly dividend per share is $0.18229 for Series A, Series B and the Series B additional payment. Ex-dividend/record dates are the last day of each month (Jan 31, Feb 28, Mar 31, 2026) and payment dates are Feb 17, Mar 16 and Apr 15, 2026. The annual preference equals 8.75% of $25.00 (or $2.1875 per share).
Series A was mandatorily converted and delisted after March 6, 2025. Series B continues to trade under CCLDO and carries scheduled redemption prices that decline over time, with special redemption terms on a Change of Control.
CareCloud (Nasdaq: CCLD) announced on Jan 8, 2026 that Affinity Urgent Care (Houston–Galveston) selected Wellsoft, the emergency department information system CareCloud acquired when it bought Medsphere in August 2025. The move brings an emergency-grade documentation platform into the urgent care channel, addressing an estimated 11,000 U.S. urgent care facilities and targeting higher-acuity, high-throughput outpatient workflows.
CareCloud positions Wellsoft alongside its AI-driven ambulatory, RCM, practice management, analytics, and patient engagement tools to support faster triage, integrated diagnostics, and staffing efficiency. Wellsoft has prior KLAS recognition as a category leader in emergency medicine through 2020.
CareCloud (NASDAQ: CCLD) announced leadership changes effective January 1, 2026 to accelerate its enterprise AI strategy and scale execution. A. Hadi Chaudhry will serve as Chief Strategy Officer to lead the company-wide AI platform and innovation; Stephen Snyder will serve as Chief Executive Officer to focus on disciplined execution, margin expansion, and scaling AI solutions across ambulatory and hospital markets.
The company highlighted recent margin expansion, improved cash flow consistency, and that it remains on track for its first year of positive EPS since going public. CareCloud also expanded into the inpatient software market via acquisitions of Medsphere Systems and the HFMA MAP App.
CareCloud (Nasdaq: CCLD) on Dec 15, 2025 launched stratusAI Desk Agent, an AI phone receptionist designed to automate patient phone access with 24/7, no-wait voice conversations and deep EHR/PM integration. The company says the solution handles front-desk workflows end-to-end, including appointment scheduling, triage, prescription refills, referrals, lab questions, and reminders. A customer quote reports the agent is managing nearly 80% of inbound calls at one practice. CareCloud positions stratusAI Desk Agent alongside stratusAI Voice Audit to deliver call monitoring, quality scoring, trending insights, and sentiment visibility. The product is available now to CareCloud customers and a live demo webinar is scheduled for Dec 17, 2025.
CareCloud (Nasdaq: CCLD / CCLDO) announced a formal plan to satisfy 14 months of unpaid dividends on its 8.75% Series B cumulative preferred stock by issuing double monthly payments starting with the January 2026 dividend (record date Jan 31, 2026; payment expected mid‑February 2026).
The arrears total approximately $3.9 million or $2.55 per share. Regular monthly dividends were fully reinstated in January 2025. The company says it will use internally generated cash flow (no common dilution) and expects arrears to be fully paid by the end of Q1 2027, while reserving the right to adjust timings for unforeseen circumstances.
CareCloud (Nasdaq: CCLD) reported third quarter 2025 results and raised full-year revenue guidance to $117–$119 million (previously $111–$114M). Q3 revenue was $31.1 million, up 9% year-over-year, marking six consecutive quarters of positive GAAP net income. Q3 GAAP net income was $3.1 million and adjusted EBITDA was $7.7 million (up 13% YoY). Nine-month revenue was $86.1 million (+4% YoY) and YTD adjusted EBITDA was $19.9 million. The company completed the Medsphere acquisition for a total purchase price of $16.5 million, reduced line-of-credit borrowings to $4.9 million, and launched an AI Center of Excellence to scale generative AI initiatives.
CareCloud (Nasdaq: CCLD) will present at the ThinkEquity Conference on October 30, 2025 at the Mandarin Oriental, New York City. The company's presentation is scheduled for 4:00 p.m. ET in the Lotus Suite East and will focus on AI innovation and its overall growth strategy.
CareCloud will also highlight four year-to-date transactions, including the Medsphere acquisition and the addition of HFMA’s MAP App, which the company says expanded its capabilities and client reach.
CareCloud (Nasdaq: CCLD) will present at the 2025 Maxim Growth Summit on October 22–23, 2025 at the Hard Rock Hotel New York City.
Presentation will highlight recent M&A activity (four transactions year‑to‑date, including the Medsphere acquisition in late August and the HFMA MAP App acquisition earlier this month), the Company’s AI roadmap and AI Center of Excellence scaling toward ~500 AI professionals, raised 2025 revenue guidance to $116–$118 million, positive free cash flow, resumption of preferred dividends, and inclusion in the Russell Microcap Index.
FAQ
What is the current stock price of CARECLOUD (CCLDO)?
